Tinidazole versus Ornidazole in Amebic Dysentery in Children (a double blind trial)
Abstract
Between January and June 1978, a double blind trial was conducted in 3.5 children, suffering from Amebic Dysentery in the OPD of the General Hospital Medan.
The children were treated ambulatory, either with Tinidazole or Ornidazole, with a dose of 50 mg/kg body weight/day for 3 consecutive days, under close supervision. All the children, except on in the Tinidazole group (case no. 20), gave excellent responses.
Disappearance of ameba's blood and mucus from the stools occurred in all of the patients after 2 days of treatment. There was no significant difference in the results of treatment with Tinidazole and Ornidazole (p>0.05). Side effects were minimal. Marked vomiting occurred in one patirnt of the Ornidazole group.
References
2. YO KlAN TJAIJ ; RAID, N. and SUTANTO, A.H. : Flagyl (Metronidazole) in the treatment of Intestinal Amoebiasis. Part. I. Paediatr. Indones. 11 : 1 (1971a). Flagyl (Metronidazole) in the treatment of Intestinal Amoebiasis. Part II. J. Singapore Paediatr. Soc. 13 : 1 1971b).
3. YO KlAN TJAIJ, RAID, N. and SU TANTO A.H. : Flagyl (Metronidazole) in the treatment of Intestinal Amoebiasis. Part. II L Paediatr. Indones. 12 : 82 (1972).
4. LUBIS, Ch. P.; NAPITUPULU, A. RUSDIDJAS; SUTANTO, AH. dan SIREGAR H. : Tinidazole pada pengobatan Disenteri Amuba, Kumpulan Naskah Pertemuan Ilmiah Tahunan ke-V Badan Koordinasi Gastroenterologi Anak Indonesia (BKGAI) hal. 385 (1977).
5. TAMSU; SUDIGBIA, I; SUMANTRI AG.; TATY HENDARTO dan KAMILAH, B.R. : Pengobatan Amoebiasis dengan Tiberal. Kumpulan Naskah Pertemuan Ilmiah Tahunan ke-V Badan Koordinasi Gastroenterologi Anak Indonesia (BKGAI hal. 394 (1977) .
Copyright (c) 2021 Amer Panggabean, Adi Sutjipto, Dachrul Aldy, A. H. Sutanto, Helena Siregar
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Published 2021-12-20